Verminoside
Cat. No.：YN310350
| 产品名称: | Verminoside |
| CAS No.: | 50932-19-9 |
| Chemical Name: | Catalpol 6-caffeate; Caffeoyl Catalpol; (1aS,1bS,2S,5aR,6S,6aS)-6-[[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-1a,1b,2,5a,6,6a-hexahydro-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl β-D-glucopyranoside |
| Synonyms: | |
| 分子量: | 524.47 |
| 分子式: | C₂₄H₂₈O₁₃ |
| SMILES: | OC[C@@]12[C@H]([C@@H](OC(/C=C/C3=CC(O)=C(O)C=C3)=O)[C@@]4([H])[C@]2([H])[C@@H](OC=C4)O[C@]5([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)CO)O1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Verminoside 是从Kigelia africana分离出的一种环烯醚萜，具有抗炎和显着的抗氧化活性，其自由基清除活性为 2.5 μg/mL。Verminoside 对人淋巴细胞的遗传毒性与PARP-1和p53蛋白水平升高有关。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Kwak, J.,et al.:Arch. Pharmacal Res.,32,207(2009)
Picerno, P., et al.: J. Nat. Prod.,68,1610(2005)
